OPEN END TURBO LONG - MERCK & CO. Share Price

Certificat

DE000MD5M2L7

Real-time Bid/Ask 09:03:24 21/06/2024 BST
3.26 EUR / 3.31 EUR +1.08% Intraday chart for OPEN END TURBO LONG - MERCK & CO.
Current month+16.49%
1 month-3.56%
Date Price Change
20/06/24 3.25 +6.91%
19/06/24 3.04 -5.59%
18/06/24 3.22 +4.89%
17/06/24 3.07 -3.46%
14/06/24 3.18 0.00%

Delayed Quote Börse Stuttgart

Last update June 20, 2024 at 08:45 pm

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellCALL
Underlying MERCK & CO., INC.
Issuer Morgan Stanley
WKN MD5M2L
ISINDE000MD5M2L7
Date issued 27/06/2022
Strike 94.95 $
Maturity Unlimited
Parity 10 : 1
Emission price 0.83
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 3.63
Lowest since issue 0.103

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
129.7 USD
Average target price
142.7 USD
Spread / Average Target
+10.03%
Consensus